Cargando…

Health Care Resource Utilization and Costs Associated with Disease Progression in Ovarian Cancer

INTRODUCTION: Ovarian cancer (OC) is one of the leading causes of cancer mortality among women in the United States. With the approval of first-line maintenance therapies, patients with OC experienced prolonged first-line progression-free survival. While the literature addresses some costs associate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simmons, Daniel, Blank, Stephanie V., ElNaggar, Adam C., Chastek, Benjamin, Bunner, Scott H., McLaurin, Kimmie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122852/ https://www.ncbi.nlm.nih.gov/pubmed/35362863 http://dx.doi.org/10.1007/s12325-022-02086-5

Ejemplares similares

The Medicaid Cost of Palivizumab
por: Ambrose, Christopher S., et al.
Publicado: (2015)

Utilization of Poly(ADP-Ribose) Polymerase Inhibitors in Ovarian Cancer: A Retrospective Cohort Study of US Healthcare Claims Data
por: Arend, Rebecca C., et al.
Publicado: (2021)

Assessing Variation in the Cost of Palivizumab for Respiratory Syncytial Virus Prevention in Preterm Infants
por: Shahabi, Ahva, et al.
Publicado: (2017)

COPD Exacerbations, Costs, and Health Care Resource Utilization Before and After Initiation of Fluticasone Furoate/Umeclidinium/Vilanterol in Routine Care in the USA
por: Hanania, Nicola A, et al.
Publicado: (2023)

Characteristics and health care utilization of otherwise healthy commercially and Medicaid-insured preterm and full-term infants in the US
por: McLaurin, Kimmie K, et al.
Publicado: (2019)

Modeling the Potential Impact of the 2014 American Academy of Pediatrics Respiratory Syncytial Virus Prophylaxis Guidance on Preterm Infant RSV Outcomes
por: McLaurin, Kimmie K., et al.
Publicado: (2015)

A Critical Appraisal and Recommendations for Cost-Effectiveness Studies of Poly(ADP-Ribose) Polymerase Inhibitors in Advanced Ovarian Cancer
por: Gao, Wei, et al.
Publicado: (2020)

Healthcare Resource Utilization and Associated Costs in Patients With Systemic Lupus Erythematosus Diagnosed With Lupus Nephritis
por: Bell, Christopher F, et al.
Publicado: (2023)

Trends in Utilization of Outpatient Respiratory Syncytial Virus Prophylaxis with Palivizumab among Medicaid- and Commercially Insured Infants
por: Pavilack, Melissa, et al.
Publicado: (2017)

Hospitalizations in the First Year of Life for Infants with Respiratory Syncytial Virus and Unspecified Bronchiolitis in a Population-Based Cohort
por: Lee, Henry, et al.
Publicado: (2017)

Population-based trends and underlying risk factors for infant respiratory syncytial virus and bronchiolitis hospitalizations
por: Bennett, Mihoko V., et al.
Publicado: (2018)

Trends in Respiratory Syncytial Virus and Bronchiolitis Hospitalization Rates in High-Risk Infants in a United States Nationally Representative Database, 1997–2012
por: Doucette, Abigail, et al.
Publicado: (2016)

Comparison of COPD health care utilization and associated costs across patients treated with LAMA+LABA fixed-dose therapies
por: Palli, Swetha R, et al.
Publicado: (2021)

A Retrospective Cohort Study Comparing Utilization and Costs of Biologic Therapies and JAK Inhibitor Therapy Across Four Common Inflammatory Indications in Adult US Managed Care Patients
por: Chastek, Benjamin, et al.
Publicado: (2016)

A randomized, controlled trial to evaluate the effect of an anti-interleukin-9 monoclonal antibody in adults with uncontrolled asthma
por: Oh, Chad K, et al.
Publicado: (2013)

National Bronchiolitis Hospitalization Rates Among Preterm and Full Term Infants: 2010–2015
por: Krilov, Leonard R, et al.
Publicado: (2017)

Progression of temporal processing deficits in the HIV-1 transgenic rat
por: McLaurin, Kristen A., et al.
Publicado: (2016)

Chronologic Age at Hospitalization for Respiratory Syncytial Virus Among Preterm and Term Infants in the United States
por: Parikh, Rohan C., et al.
Publicado: (2017)

Impact of Respiratory Syncytial Virus–Confirmed Hospitalizations on Caregivers of US Preterm Infants
por: Pokrzywinski, Robin M., et al.
Publicado: (2019)

Respiratory Syncytial Virus Hospitalizations among U.S. Preterm Infants Compared with Term Infants Before and After the 2014 American Academy of Pediatrics Guidance on Immunoprophylaxis: 2012–2016
por: Goldstein, Mitchell, et al.
Publicado: (2018)

Disruption of Timing: NeuroHIV Progression in the Post-cART Era
por: McLaurin, Kristen A., et al.
Publicado: (2019)

Integrin-Linked Kinase Is a Novel Therapeutic Target in Ovarian Cancer
por: Ulm, Michael A., et al.
Publicado: (2020)

Addition of Everolimus Post VEGFR Inhibition Treatment Failure in Advanced Sarcoma Patients Who Previously Benefited from VEGFR Inhibition: A Case Series
por: ElNaggar, Adam C., et al.
Publicado: (2016)

The 2014–2015 National Impact of the 2014 American Academy of Pediatrics Guidance for Respiratory Syncytial Virus Immunoprophylaxis on Preterm Infants Born in the United States
por: Kong, Amanda M., et al.
Publicado: (2018)

Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants
por: McLaurin, K K, et al.
Publicado: (2016)

Resource Utilization and Costs of Care prior to ART Initiation for Pediatric Patients in Zambia
por: Iyer, Hari S., et al.
Publicado: (2014)

Drivers of business model innovation in micro and small enterprises: evidence from Egypt as an emerging economy
por: ElNaggar, Rasha A. A., et al.
Publicado: (2023)

Incidence and contributing factors to termination of the patient-physician relationship
por: Santoso, Joseph T., et al.
Publicado: (2016)

Clinical characteristics, healthcare use, and annual costs among patients with dystrophic epidermolysis bullosa
por: Feinstein, James A., et al.
Publicado: (2022)

Data on Utility in Cost–Utility Analyses of Genetic Screen-and-Treat Strategies for Breast and Ovarian Cancer
por: Simões Corrêa Galendi, Julia, et al.
Publicado: (2021)

Rapid Nanoparticle Synthesis by Magnetic and Microwave Heating
por: Chikan, Viktor, et al.
Publicado: (2016)

Impact of Frailty on Health Care Resource Utilization and Costs of Care in Myelodysplastic Syndromes
por: Mozessohn, Lee, et al.
Publicado: (2023)

Treatment Persistence and Healthcare Costs Among Patients with Rheumatoid Arthritis Changing Biologics in the USA
por: Chastek, Benjamin, et al.
Publicado: (2017)

Tradeoff between lag time and growth rate drives the plasmid acquisition cost
por: Ahmad, Mehrose, et al.
Publicado: (2023)

Resource Utilization and Costs of Age-Related Macular Degeneration
por: Halpern, Michael T., et al.
Publicado: (2006)

Utilization and cost of electronic resources in adult cancer center
por: Maraiki, Fatma, et al.
Publicado: (2018)

Mechanisms of Amyloid-Beta Peptide Uptake by Neurons: The Role of Lipid Rafts and Lipid Raft-Associated Proteins
por: Lai, Aaron Y., et al.
Publicado: (2010)

Healthcare Resource Utilization and Costs Associated with Autosomal Dominant Polycystic Kidney Disease
por: Blanchette, Christopher M., et al.
Publicado: (2014)

COPD exacerbation frequency and its association with health care resource utilization and costs
por: Dhamane, Amol D, et al.
Publicado: (2015)

Impact of antiepileptic-drug treatment burden on health-care-resource utilization and costs
por: Rajagopalan, Krithika, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_uuqvd31m91qan21ck2cbk5p0il